Is This Drug a Statin Alternative?
METHODOLOGY:
Previous studies have shown the efficacy of inclisiran in lowering the level of LDL cholesterol when used in combination with statins in patients with a high risk for atherosclerosis; however, its efficacy as a monotherapy without statins remains uncertain.
Researchers conducted a 6-month multinational, randomized, phase 3 study to compare the efficacy and safety of inclisiran with those of placebo or ezetimibe in reducing levels of LDL cholesterol.
They included 350 participants (mean age, 46.1 years; 62.6% women) with no history of atherosclerotic cardiovascular disease , diabetes, or familial hypercholesterolemia and a fasting LDL cholesterol level of 100-190 mg/dL.
Participants were randomly assigned to receive subcutaneous inclisiran (n = 174), oral ezetimibe (n = 89), or matching placebo (n = 87), with inclisiran administered on days 1 and 90.
The primary endpoint was the percentage change in the level of LDL cholesterol from baseline to day 150; several secondary endpoints, including the absolute change in LDL and safety, were assessed.
TAKEAWAY:
By day 150, participants who received inclisiran showed a 47.9% greater reduction in the level of LDL cholesterol than those who received placebo and a 35.4% greater reduction than those who received ezetimibe ( P < .0001 for both).
< .0001 for both). The absolute reduction in the level of LDL cholesterol and the percentage reduction in PCSK9 levels were also greater in participants who received inclisiran than in those who received placebo or ezetimibe ( P < .0001 for all).
< .0001 for all). In the group who received inclisiran, levels of lipoprotein(a) decreased by 25.2% compared with placebo ( P = .001) and by 24.3% compared with ezetimibe ( P = .0002) by day 150.
= .001) and by 24.3% compared with ezetimibe ( = .0002) by day 150. Similar rates of treatment-emergent adverse events were noted across the three groups, with no new safety concerns.
IN PRACTICE:
'There is a significant unmet clinical need for therapies that address both statin intolerance and adherence in primary prevention,' the researchers noted. 'Inclisiran is potentially uniquely positioned to meet these challenges owing to its first-in-class mechanism of action, favorable safety profile, and infrequent twice-yearly dosing,' they added.
SOURCE:
This study was led by Pam R. Taub, MD, of the University of California in San Diego. It was published online on June 9, 2025, in Journal of the American College of Cardiology .
LIMITATIONS:
A short follow-up duration and limited sample size prevented the researchers from evaluating the cardiovascular outcomes of lowering the level of LDL cholesterol with inclisiran. The analysis lacked direct comparison with statins, anti-PCSK9 monoclonal antibodies, or bempedoic acid. The response of LDL with ezetimibe was lower than that observed in other studies.
DISCLOSURES:
This study received funding from Novartis Pharma. Two authors reported receiving compensation for serving as principal investigators of this trial, and another author reported serving as a consultant for multiple pharmaceutical companies including the funding agency. Several other authors reported serving as employees of the US or Switzerland wings of the funding agency or being principal investigator, consultants, and/or holding shares in the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
New Genetic Test Predicts Children With Future Risk of High BMI
A new test helps predict which kids face the largest genetic risk of a high body mass index (BMI) later in life. That could help parents establish healthy habits early on. The new test, put together by a large team of international researchers, is what's known as a polygenic score or PGS. These scores are used to group genetic variations to predict a certain characteristic, which in this case is BMI. Related: "What makes the score so powerful is its ability to predict, before the age of five, whether a child is likely to develop obesity in adulthood, well before other risk factors start to shape their weight later in childhood," says genetic epidemiologist Roelof Smit, from the University of Copenhagen in Denmark. "Intervening at this point can have a huge impact." It's important to note that the test isn't quite as straightforward as it might sound. For one, genetics only accounts for a relatively small proportion of risk for high BMI. And secondly, a growing body of research is suggesting we move away from BMI as a measure of obesity and health in general. Still, the researchers claim the new PGS test is up to twice as accurate as others of its type. It was built from a database of genetic information collected from more than 5.1 million people. After compiling the test, the researchers then tried it out on several separate health databases, covering hundreds of thousands of individuals. In these datasets, both genetic data and BMI over time had been recorded. The researchers added the PGS to other predictors of BMI, and found that higher PGS scores were associated with greater adult weight gain. The accuracy of the PGS at predicting BMI variation depended on age and ancestry. PGS scores at the age of 5 explained 35 percent of the BMI variation at age 18. For middle-aged Europeans, it accounted for 17.6 percent of the variation. In other groups it was much lower: just 2.2 percent for rural Ugandans, for example. This is probably down to underrepresentation in the training data, and the greater genetic diversity in African populations, the researchers say. Another interesting finding from the study: those with stronger genetic predisposition towards having a higher BMI actually lost more weight during the first year of weight loss programs, although they were also more likely to regain weight later. "Our findings emphasize that individuals with a high genetic predisposition to obesity may respond more to lifestyle changes and, thus, contrast with the determinist view that genetic predisposition is unmodifiable," write the researchers in their published paper. The thinking is that if BMI can be predicted more accurately at an early age, that gives those kids and their parents a bigger window of time to instill healthier habits regarding diet or activity levels, which have the potential to influence BMI. "This new polygenic score is a dramatic improvement in predictive power and a leap forward in the genetic prediction of obesity risk, which brings us much closer to clinically useful genetic testing," says geneticist Ruth Loos, from the University of Copenhagen. The research has been published in Nature Medicine. Related News This Diet Helps Lower Dementia Risk, And We May Finally Know Why A Signal of Future Alzheimer's Could Hide in The Way You Speak Something Inside Your Gut Could Be Like a Natural Ozempic Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
World First: Scientists Film The Exact Moment a Human Embryo Implants
Scientists have for the first time ever filmed a crucial step that leads to new human life – cracking open a 'black box' of early development, and potentially helping with fertility treatments. Every human alive today was once nothing more than a free-floating clump of cells looking for a suitable place to call home. Despite the odds, our embryos did it: they became one with our mother's body. This achievement, known as implantation, occurs deep within the uterus, and until now, scientists had only taken snapshots of the phenomenon. It takes weeks before an ultrasound can glimpse anything in the darkness. Related: A new system now lets researchers take a closer look at the surprisingly invasive process. Time-lapse recordings show human embryos in the lab aggressively penetrating a collagen-based matrix to create a cavity for connection and further growth. "For the first time, we've been able to watch human embryo implantation unfold dynamically," senior author and bioengineer Samuel Ojosnegros of the Barcelona Institute of Science and Technology (BIST) told ScienceAlert. "We've opened a window into a stage of development that was previously hidden." The experiments took place in the lab, not in a real uterus; however, the platform developed by Ojosnegros and his colleagues recreates the right structural environment and nutrients for donated embryos to implant. This is a critical step that can easily go wrong under natural conditions. Roughly 60 percent of failed pregnancies happen during implantation or soon after, making this stage a key bottleneck to life. Compared to mouse embryos, which only invaded the matrix superficially, researchers found that human embryos drill deep, fully wrapping themselves in the collagen matrix. "Our technology lets us pinpoint where the embryo exerts force, and we found it applies significant mechanical force to implant and invade," said Ojosnegros. "This means that mouse studies can only take us so far in understanding human implantation." A human embryo typically implants five to six days after fertilization (when egg and sperm meet). At this stage, the embryo is a cluster of 100 to 200 cells – too small to be seen using ultrasound. In the past, this meant that researchers could mainly watch the first five days of embryo development in the lab. The new uterine model developed by Ojosnegros and his colleagues widens the window, extending embryo observation beyond that initial first stage. The technology can be used as a flat gel or as a droplet to observe embryo implantation in 2D or 3D. When blastocysts are left on top of a flat gel, they can be seen binding to the collagen surface and then invading it. When they are placed inside the droplets, meanwhile, the embryos seem to 'pull' the collagen fibers of the mother's tissues toward their center, remodeling the environment around themselves. Lead author of the study Amélie Luise Godeau from BIST and her team speculate that the embryo is somehow connecting the maternal environment with its own tissues. What the uterine wall might do in response to that is beyond the scope of the study. The collagen-based matrix is not made using human uterine cells, so it can only provide half the picture. That limitation, however, also offers an advantage. The composition of the matrix can be tweaked to see how human embryos respond to different environments or compounds that might improve implantation. "For example, through our spin-off, Serabiotics, and in collaboration with the pharmaceutical company Grifols, we've developed a protein supplement that can be used in clinics to enhance implantation rates," said Ojosnegros, the cofounder of Serabiotics. The study was published in Science Advances. Related News Chlorophyll & Collagen: Does Science Back TikTok's Favorite Supplements? Aging Can Spread Through Your Body Via a Single Protein, Study Finds New Genetic Test Predicts Children With Future Risk of High BMI Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
There's a Surprisingly Easy Way to Remove Microplastics in Your Drinking Water
Tiny fragments of plastics are making their way deep inside our bodies in concerning quantities, particularly through our food and drink. In 2024, scientists in China found a simple and effective means of removing them from water. The team ran tests on both soft water and hard tap water (which is richer in minerals). They added in nanoplastics and microplastics before boiling the liquid and then filtering out any precipitates. Related: "Tap water nano/microplastics (NMPs) escaping from centralized water treatment systems are of increasing global concern, because they pose potential health risks to humans via water consumption," the researchers from Guangzhou Medical University and Jinan University write in their published paper. In some cases, up to 90 percent of the NMPs were removed by the boiling and filtering process, though the effectiveness varied based on the type of water. Of course the big benefit is that most people can do it with what they already have in their kitchen. "This simple boiling water strategy can 'decontaminate' NMPs from household tap water and has the potential for harmlessly alleviating human intake of NMPs through water consumption," write biomedical engineer Zimin Yu from Guangzhou Medical University and colleagues. A greater concentration of NMPs was removed from samples of hard tap water, which naturally forms a buildup of limescale (or calcium carbonate) as it is heated. Commonly seen inside kitchen kettles, the chalky substance forms on the plastic's surface as changes in temperature force the calcium carbonate out of solution, effectively trapping the plastic fragments in a crust. "Our results showed that nanoplastic precipitation efficiency increased with increasing water hardness upon boiling," the team writes. "For example, from 34 percent at 80 mg L−1 to 84 percent and 90 percent at 180 and 300 mg L−1 of calcium carbonate, respectively." Even in soft water, where less calcium carbonate is dissolved, roughly a quarter of the NMPs were snagged from the water. Any bits of lime-encrusted plastic could then be removed through a simple filter like the stainless steel mesh used to strain tea, the researchers say. Past studies have measured fragments of polystyrene, polyethylene, polypropylene, and polyethylene terephthalate in potable tap water, which we're consuming daily in varying quantities. To put the strategy to the ultimate test, the researchers added even more nanoplastic particles, which were effectively reduced in number. "Drinking boiled water apparently is a viable long-term strategy for reducing global exposure to NMPs," write the researchers. "Drinking boiled water, however, is often regarded as a local tradition and prevails only in a few regions." The research team hopes that drinking boiled water might become a more widespread practice as plastics continue to take over the world. While it's still not certain exactly how damaging this plastic is to our bodies, it's clearly not the healthiest of snacks. Plastics have already been linked to changes in the gut microbiome and the body's antibiotic resistance. The team behind this latest study wants to see more research into how boiled water could keep artificial materials out of our bodies – and perhaps counter some of the alarming effects of microplastics that are emerging. "Our results have ratified a highly feasible strategy to reduce human NMP exposure and established the foundation for further investigations with a much larger number of samples," write the authors. The research has been published in Environmental Science & Technology Letters. An earlier version of this article was published in March 2024. Related News World First: Scientists Film The Exact Moment a Human Embryo Implants Chlorophyll & Collagen: Does Science Back TikTok's Favorite Supplements? Aging Can Spread Through Your Body Via a Single Protein, Study Finds Solve the daily Crossword
